中文 | English
Return
Total: 5 , 1/1
Show Home Prev Next End page: GO
MeSH:(Muscarinic Antagonists/adverse effects)

1.Comparisons of efficacy and safety of tolterodine and oxybutynin in children with idiopathic overactive bladder.

Yong-Ji DENG ; Geng MA ; Yun-Fei GUO ; Zheng GE ; Ru-Gang LU ; Li-Xia WANG ; Hao-Bo ZHU ; Chen-Jun CHEN

Chinese Journal of Contemporary Pediatrics 2011;13(1):26-28

2.Efficacy and safety of combined therapy with terazosin and tolteradine for patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a prospective study.

Yong YANG ; Xiao-feng ZHAO ; Han-zhong LI ; Wei WANG ; Yong ZHANG ; He XIAO ; Xin ZHANG

Chinese Medical Journal 2007;120(5):370-374

3.Efficacy, Tolerability, and Safety of Oxybutynin Chloride in Pediatric Neurogenic Bladder With Spinal Dysraphism: A Retrospective, Multicenter, Observational Study.

Jung Hoon LEE ; Kyoung Rok KIM ; Yong Seung LEE ; Sang Won HAN ; Kun Suk KIM ; Sang Hoon SONG ; Minki BAEK ; Kwanjin PARK

Korean Journal of Urology 2014;55(12):828-833

4.Microinjection of M(5) muscarinic receptor antisense oligonucleotide into VTA inhibits FosB expression in the NAc and the hippocampus of heroin sensitized rats.

Hui-Fen LIU ; Wen-Hua ZHOU ; Hua-Qiang ZHU ; Miao-Jun LAI ; Wei-Sheng CHEN

Neuroscience Bulletin 2007;23(1):1-8

5.Characteristics of urinary retention in female inpatients managed with medical treatments.

Chang Yong LEE ; Chul Sung KIM ; Won Jin CHO

Korean Journal of Urology 2015;56(12):817-822

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 5 , 1/1 Show Home Prev Next End page: GO